Neurologic - Ipsen

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT06047457

A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Episodic Migraine in Adult Participants

Drug

Botulinum toxin type A

Phase

Phase III

Condition

Migraine, Episodic Migraine, Headache

Keywords

Migraine | Episodic Migraine | Headache